Global Bispecific Antibodies for Cancer Market 2025-2029

Description

List of Tables

The bispecific antibodies for cancer market is forecasted to grow by USD 338 million during 2024-2029, accelerating at a CAGR of 6.9% during the forecast period. The report on the bispecific antibodies for cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer, advantages of bispecific antibodies over monoclonal antibodies, and strong pipeline of bispecific antibodies.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	6.4%
CAGR	6.9%
Incremental Value	$338 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's bispecific antibodies for cancer market is segmented as below:

By Type

CD19 or CD3
CD30 or CD16A

By Distribution Channel

Hospitals
Retail pharmacies
Online

By Action Mechanism

Dual antigen targeting
Dual-blocking antibodies
T-cell engagers

By Therapeutic Area

Oncology
Autoimmune diseases
Infectious diseases
Neurological disorders

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emerging bispecific antibody generation platforms as one of the prime reasons driving the bispecific antibodies for cancer market growth during the next few years. Also, increase in strategic alliances and emergence of combination therapy will lead to sizable demand in the market.

The report on the bispecific antibodies for cancer market covers the following areas:

Bispecific Antibodies For Cancer Market sizing
Bispecific Antibodies For Cancer Market forecast
Bispecific Antibodies For Cancer Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bispecific antibodies for cancer market vendors that include ABL Bio Inc., AFFIMED N.V., Akeso Inc., Amgen Inc., Aptevo Therapeutics Inc., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Eli Lilly and Co., EPIMAB BIOTHERAPEUTICS INC., F STAR THERAPEUTICS INC., F. Hoffmann La Roche Ltd., Glenmark Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Mereo BioPharma Group PLC, Merus N.V., Pfizer Inc., Regeneron Pharmaceuticals Inc., TG Therapeutics Inc., Xencor Inc., and Y mAbs Therapeutics Inc.. Also, the bispecific antibodies for cancer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR72677

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Action Mechanism
- Executive Summary - Chart on Market Segmentation by Therapeutic Area
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Bispecific Antibodies For Cancer Market 2019 - 2023
- Historic Market Size - Data Table on Global Bispecific Antibodies For Cancer Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Action Mechanism segment analysis 2019 - 2023
- Historic Market Size - Action Mechanism Segment 2019 - 2023 ($ million)
5.5 Therapeutic Area segment analysis 2019 - 2023
- Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global Bispecific Antibodies for Cancer Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
8.3 CD19 or CD3 - Market size and forecast 2024-2029
- Chart on CD19 or CD3 - Market size and forecast 2024-2029 ($ million)
- Data Table on CD19 or CD3 - Market size and forecast 2024-2029 ($ million)
- Chart on CD19 or CD3 - Year-over-year growth 2024-2029 (%)
- Data Table on CD19 or CD3 - Year-over-year growth 2024-2029 (%)
8.4 CD30 or CD16A - Market size and forecast 2024-2029
- Chart on CD30 or CD16A - Market size and forecast 2024-2029 ($ million)
- Data Table on CD30 or CD16A - Market size and forecast 2024-2029 ($ million)
- Chart on CD30 or CD16A - Year-over-year growth 2024-2029 (%)
- Data Table on CD30 or CD16A - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
9.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
9.4 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Action Mechanism

10.1 Market segments
- Chart on Action Mechanism - Market share 2024-2029 (%)
- Data Table on Action Mechanism - Market share 2024-2029 (%)
10.2 Comparison by Action Mechanism
- Chart on Comparison by Action Mechanism
- Data Table on Comparison by Action Mechanism
10.3 Dual antigen targeting - Market size and forecast 2024-2029
- Chart on Dual antigen targeting - Market size and forecast 2024-2029 ($ million)
- Data Table on Dual antigen targeting - Market size and forecast 2024-2029 ($ million)
- Chart on Dual antigen targeting - Year-over-year growth 2024-2029 (%)
- Data Table on Dual antigen targeting - Year-over-year growth 2024-2029 (%)
10.4 Dual-blocking antibodies - Market size and forecast 2024-2029
- Chart on Dual-blocking antibodies - Market size and forecast 2024-2029 ($ million)
- Data Table on Dual-blocking antibodies - Market size and forecast 2024-2029 ($ million)
- Chart on Dual-blocking antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Dual-blocking antibodies - Year-over-year growth 2024-2029 (%)
10.5 T-cell engagers - Market size and forecast 2024-2029
- Chart on T-cell engagers - Market size and forecast 2024-2029 ($ million)
- Data Table on T-cell engagers - Market size and forecast 2024-2029 ($ million)
- Chart on T-cell engagers - Year-over-year growth 2024-2029 (%)
- Data Table on T-cell engagers - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Action Mechanism
- Market opportunity by Action Mechanism ($ million)
- Data Table on Market opportunity by Action Mechanism ($ million)

11 Market Segmentation by Therapeutic Area

11.1 Market segments
- Chart on Therapeutic Area - Market share 2024-2029 (%)
- Data Table on Therapeutic Area - Market share 2024-2029 (%)
11.2 Comparison by Therapeutic Area
- Chart on Comparison by Therapeutic Area
- Data Table on Comparison by Therapeutic Area
11.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
11.4 Autoimmune diseases - Market size and forecast 2024-2029
- Chart on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Autoimmune diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Autoimmune diseases - Year-over-year growth 2024-2029 (%)
11.5 Infectious diseases - Market size and forecast 2024-2029
- Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
- Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
11.6 Neurological disorders - Market size and forecast 2024-2029
- Chart on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurological disorders - Market size and forecast 2024-2029 ($ million)
- Chart on Neurological disorders - Year-over-year growth 2024-2029 (%)
- Data Table on Neurological disorders - Year-over-year growth 2024-2029 (%)
11.7 Market opportunity by Therapeutic Area
- Market opportunity by Therapeutic Area ($ million)
- Data Table on Market opportunity by Therapeutic Area ($ million)

12 Customer Landscape

12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

13.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Ireland - Market size and forecast 2024-2029
- Chart on Ireland - Market size and forecast 2024-2029 ($ million)
- Data Table on Ireland - Market size and forecast 2024-2029 ($ million)
- Chart on Ireland - Year-over-year growth 2024-2029 (%)
- Data Table on Ireland - Year-over-year growth 2024-2029 (%)
13.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.10 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
13.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
13.12 Hungary - Market size and forecast 2024-2029
- Chart on Hungary - Market size and forecast 2024-2029 ($ million)
- Data Table on Hungary - Market size and forecast 2024-2029 ($ million)
- Chart on Hungary - Year-over-year growth 2024-2029 (%)
- Data Table on Hungary - Year-over-year growth 2024-2029 (%)
13.13 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.15 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
13.16 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

14 Drivers, Challenges, and Opportunity/Restraints

14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints

15 Competitive Landscape

15.1 Overview
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
- Overview on factors of disruption
15.4 Industry risks
- Impact of key risks on business

16 Competitive Analysis

16.1 Companies profiled
- Companies covered
16.2 Company ranking index
- Company ranking index
16.3 Market positioning of companies
- Matrix on companies position and classification
16.4 ABL Bio Inc.
- ABL Bio Inc. - Overview
- ABL Bio Inc. - Product / Service
- ABL Bio Inc. - Key offerings
- SWOT
16.5 AFFIMED N.V.
- AFFIMED N.V. - Overview
- AFFIMED N.V. - Product / Service
- AFFIMED N.V. - Key offerings
- SWOT
16.6 Akeso Inc.
- Akeso Inc. - Overview
- Akeso Inc. - Product / Service
- Akeso Inc. - Key offerings
- SWOT
16.7 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
16.8 Aptevo Therapeutics Inc.
- Aptevo Therapeutics Inc. - Overview
- Aptevo Therapeutics Inc. - Product / Service
- Aptevo Therapeutics Inc. - Key offerings
- SWOT
16.9 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
16.10 Chugai Pharmaceutical Co. Ltd.
- Chugai Pharmaceutical Co. Ltd. - Overview
- Chugai Pharmaceutical Co. Ltd. - Product / Service
- Chugai Pharmaceutical Co. Ltd. - Key news
- Chugai Pharmaceutical Co. Ltd. - Key offerings
- SWOT
16.11 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
16.12 EPIMAB BIOTHERAPEUTICS INC.
- EPIMAB BIOTHERAPEUTICS INC. - Overview
- EPIMAB BIOTHERAPEUTICS INC. - Product / Service
- EPIMAB BIOTHERAPEUTICS INC. - Key offerings
- SWOT
16.13 F STAR THERAPEUTICS INC.
- F STAR THERAPEUTICS INC. - Overview
- F STAR THERAPEUTICS INC. - Product / Service
- F STAR THERAPEUTICS INC. - Key offerings
- SWOT
16.14 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
16.15 Glenmark Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Ltd. - Overview
- Glenmark Pharmaceuticals Ltd. - Product / Service
- Glenmark Pharmaceuticals Ltd. - Key offerings
- SWOT
16.16 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
16.17 Mereo BioPharma Group Plc
- Mereo BioPharma Group Plc - Overview
- Mereo BioPharma Group Plc - Product / Service
- Mereo BioPharma Group Plc - Key offerings
- SWOT
16.18 Merus N.V.
- Merus N.V. - Overview
- Merus N.V. - Product / Service
- Merus N.V. - Key offerings
- SWOT

17 Appendix

17.1 Scope of the report
17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
17.3 Currency conversion rates for US$
- Currency conversion rates for US$
17.4 Research methodology
- Research methodology
17.5 Data procurement
- Information sources
17.6 Data validation
- Data validation
17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
17.8 Data synthesis
- Data synthesis
17.9 360 degree market analysis
- 360 degree market analysis
17.10 List of abbreviations
- List of abbreviations